DK1078263T3 - Fremgangsmåde til direkte selektion af antigen-specifikke T-celler - Google Patents

Fremgangsmåde til direkte selektion af antigen-specifikke T-celler

Info

Publication number
DK1078263T3
DK1078263T3 DK99924167T DK99924167T DK1078263T3 DK 1078263 T3 DK1078263 T3 DK 1078263T3 DK 99924167 T DK99924167 T DK 99924167T DK 99924167 T DK99924167 T DK 99924167T DK 1078263 T3 DK1078263 T3 DK 1078263T3
Authority
DK
Denmark
Prior art keywords
cells
antigen
product
labeled
specific
Prior art date
Application number
DK99924167T
Other languages
Danish (da)
English (en)
Inventor
Stefan Miltenyi
Mario Assenmacher
Jurgen Schmitz
Original Assignee
Miltenyi Biotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miltenyi Biotec Gmbh filed Critical Miltenyi Biotec Gmbh
Application granted granted Critical
Publication of DK1078263T3 publication Critical patent/DK1078263T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99924167T 1998-05-11 1999-05-10 Fremgangsmåde til direkte selektion af antigen-specifikke T-celler DK1078263T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8513698P 1998-05-11 1998-05-11
PCT/US1999/010200 WO1999058977A1 (en) 1998-05-11 1999-05-10 Method of direct selection of antigen-specific t cells

Publications (1)

Publication Number Publication Date
DK1078263T3 true DK1078263T3 (da) 2009-11-02

Family

ID=22189678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99924167T DK1078263T3 (da) 1998-05-11 1999-05-10 Fremgangsmåde til direkte selektion af antigen-specifikke T-celler

Country Status (10)

Country Link
US (2) US6576428B1 (enExample)
EP (1) EP1078263B1 (enExample)
JP (1) JP4601166B2 (enExample)
AT (1) ATE437366T1 (enExample)
AU (1) AU765085B2 (enExample)
CA (1) CA2330678C (enExample)
DE (1) DE69941150D1 (enExample)
DK (1) DK1078263T3 (enExample)
ES (1) ES2328650T3 (enExample)
WO (1) WO1999058977A1 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191677T3 (es) * 1992-10-21 2003-09-16 Stefan Miltenyi Seleccion directa de celulas mediante un producto de secrecion.
US7166423B1 (en) 1992-10-21 2007-01-23 Miltenyi Biotec Gmbh Direct selection of cells by secretion product
KR20010072957A (ko) * 1998-08-24 2001-07-31 추후보정 Ｈ2 수용체 작용제 및 기타 ｔ-세포 활성화제를 사용한ｔ-세포(ｃｄ4+ 및 ｃｄ8+) 활성화 및 보호 방법
US7807377B2 (en) * 1998-10-20 2010-10-05 Salvatore Albani Method of isolating antigen-specific T cells employing artificial antigen presenting cells
US20020044656A1 (en) * 1999-10-13 2002-04-18 Brant L. Candelore Interfacing a conditional access circuit to a digital device using input and output stream switching
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) * 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
ATE367816T1 (de) 2000-05-12 2007-08-15 Univ Oregon Health & Science Verwendung von niedrigen dosen estrogen in kombination mit immunotherapeutischen verbindungen zur behandlung von immunkrankheiten
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
JP2002365286A (ja) * 2000-11-13 2002-12-18 Kyogo Ito 細胞性免疫検出法およびその医薬への応用
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
US6919183B2 (en) 2001-01-16 2005-07-19 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
GB0118337D0 (en) * 2001-07-27 2001-09-19 Lonza Biologics Plc Method for selecting antibody expressing cells
EP1473564A4 (en) * 2001-09-18 2008-12-10 Greenpeptide Co Ltd METHOD FOR DETECTING CELL IMMUNITY AND ITS APPLICATION TO MEDICAMENTS
US20050084967A1 (en) * 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
AU2003253684A1 (en) * 2002-06-28 2004-01-19 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
EP1420253B1 (de) * 2002-08-23 2006-05-31 Deutsches Rheuma-Forschungszentrum Berlin Verfahren zum Nachweis und zur Isolierung von T-Lymphozyten, die ein definiertes Antigen erkennen
EP1570267B1 (en) 2002-12-03 2011-10-12 UCB Pharma, S.A. Assay for identifying antibody producing cells
US20040248205A1 (en) * 2003-04-16 2004-12-09 Stern Lawrence J. Major histocompatibility complex (MHC)-peptide arrays
DK1623017T3 (da) * 2003-05-08 2011-01-10 Life Technologies Corp Frembringelse og isolering af antigenspecifikke T-celler
EP1658498A1 (en) 2003-08-20 2006-05-24 Celltech R & D Limited Methods for obtaining antibodies
WO2005031357A2 (en) * 2003-09-24 2005-04-07 Ucl Biomedica Plc. Cell sample analysis
US20060051358A1 (en) * 2004-05-24 2006-03-09 Baylor Research Institute Immune response assessment method
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
GB0412973D0 (en) * 2004-06-10 2004-07-14 Celltech R&D Ltd Identification of antibody producing cells
US8053197B2 (en) 2004-07-30 2011-11-08 Oregon Health & Science University Methods for detecting and treating autoimmune disorders
EP1812563B1 (en) * 2004-10-29 2013-04-10 Benaroya Research Institute at Virginia Mason Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use
WO2006124356A2 (en) * 2005-05-16 2006-11-23 The Rockefeller University Method for isolating dermal papilla cells and uses thereof
US7867765B2 (en) 2005-12-28 2011-01-11 The General Hospital Corporation Blood cell sorting methods and systems
EP1878744A1 (en) * 2006-07-13 2008-01-16 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
EP2079483A4 (en) * 2006-07-29 2010-10-20 Robert Lamar Bjork Jr BISPECIFIC MONOCLONAL ANTIBODIES (SPECIFIC FOR CD3 AND CD11B) THERAPEUTIC MEDICAMENTS
CN101221171B (zh) * 2007-12-11 2011-07-20 广州益善生物技术有限公司 用于骨代谢生化标志物检测的液相芯片及其制备方法
WO2009103753A1 (en) * 2008-02-20 2009-08-27 Ablynx Nv Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods
EP2306959A2 (en) * 2008-07-11 2011-04-13 The General Hospital Corporation Magnetic apparatus for blood separation
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
GB0823553D0 (en) * 2008-12-24 2009-01-28 Immunosolv Ltd Cell separation technique
US20120045827A1 (en) * 2009-03-09 2012-02-23 Biofactura, Inc. Separation of antigen-specific memory b cells with a conjugated biopolymer surface
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
CN102033129A (zh) * 2009-09-29 2011-04-27 上海英伯肯医学生物技术有限公司 用抗原刺激的细胞免疫反应来检测病原微生物的方法及测试笔
EP2390661B1 (en) 2010-05-02 2015-06-24 Miltenyi Biotec GmbH An anchoring/capturing means for selecting or analyzing a CHO cell according to a product secreted by the CHO cell
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
EP2518504A1 (en) * 2011-04-29 2012-10-31 Miltenyi Biotec GmbH A method for the quantitative and qualitative characterization of antigen-specific T cells recognizing a specific antigen
JP2014516538A (ja) 2011-05-26 2014-07-17 ジーニウス バイオテクノロジー インベストメンツ リミテッド ライアビリティ カンパニー 調節された免疫優勢療法
US10434121B2 (en) 2011-12-22 2019-10-08 Yeda Research And Development Co. Ltd. Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
BR112015004374B1 (pt) 2012-08-29 2021-02-09 Inguran, Llc método de manipulação celular magnética
US10379026B2 (en) 2012-08-29 2019-08-13 Inguran, Llc Cell processing using magnetic particles
TWI675044B (zh) 2012-11-14 2019-10-21 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
CN103901188B (zh) * 2014-04-11 2016-08-24 苏州浩欧博生物医药有限公司 一种吸入过敏原的化学发光定量检测试剂盒及其制备方法和检测方法
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN109153975A (zh) * 2015-12-28 2019-01-04 诺华股份有限公司 制备嵌合抗原受体表达细胞的方法
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
CN109715788A (zh) * 2016-06-28 2019-05-03 金纽斯生物科技公司 用于免疫疗法的t细胞组合物
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
EP3662057A4 (en) * 2017-08-01 2021-04-28 Benaroya Research Institute at Virginia Mason PRO-ALLERGIC SPECIFIC T-LYMPHOCYTES IDENTIFICATION AND SEPARATION PROCESSES
CN110857948B (zh) * 2018-08-24 2025-01-21 武汉纳达康生物科技有限公司 H7禽流感病毒抗体磁免疫化学发光检测试剂盒及其应用
CN112930355A (zh) * 2018-10-19 2021-06-08 苏黎世联邦理工学院 嵌合分子
WO2021030606A1 (en) * 2019-08-14 2021-02-18 Sanford Burnham Prebys Medical Discovery Institute Methods and devices for rare cell capture
JP2022093945A (ja) * 2020-12-14 2022-06-24 株式会社山田養蜂場本社 Ｂ細胞数増加剤
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN117433867A (zh) * 2023-10-24 2024-01-23 深圳联合医学科技有限公司 阴道微生物的荧光染色液及检测阴道微生物的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4452773A (en) 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
GB8408127D0 (en) 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
IL91414A0 (en) 1988-08-31 1990-04-29 Zynaxis Technologies Inc Reagents and methods for the determination of analytes
US5385707A (en) 1988-12-28 1995-01-31 Stefan Miltenyi Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same
ATE114507T1 (de) 1988-12-28 1994-12-15 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
ES2191677T3 (es) * 1992-10-21 2003-09-16 Stefan Miltenyi Seleccion directa de celulas mediante un producto de secrecion.
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
WO1996037208A1 (en) 1995-05-25 1996-11-28 Baxter International Inc. Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
WO1997005239A1 (en) 1995-07-25 1997-02-13 Celltherapy, Inc. Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
AU740222C (en) 1996-03-20 2002-10-10 Genzyme Corporation A method for identifying cytotoxic T-cell epitopes
CA2254975C (en) 1996-05-23 2008-12-16 The Scripps Research Institute Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
US5750356A (en) 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity

Also Published As

Publication number Publication date
JP2002514765A (ja) 2002-05-21
AU4073699A (en) 1999-11-29
ES2328650T3 (es) 2009-11-16
US6576428B1 (en) 2003-06-10
US20040023377A1 (en) 2004-02-05
ATE437366T1 (de) 2009-08-15
DE69941150D1 (de) 2009-09-03
CA2330678C (en) 2009-04-07
WO1999058977A1 (en) 1999-11-18
EP1078263B1 (en) 2009-07-22
CA2330678A1 (en) 1999-11-18
AU765085B2 (en) 2003-09-11
JP4601166B2 (ja) 2010-12-22
EP1078263A1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
DK1078263T3 (da) Fremgangsmåde til direkte selektion af antigen-specifikke T-celler
CA2146974A1 (en) Direct selection of cells by secretion product
EP0347039A3 (en) Method for discriminating between intact and damaged cells in a sample
DK0749580T3 (da) Fremgangsmåde og indretning til detektion af specifikke målceller i specialiserede eller blandede cellepopulationer og oplø
PL328272A1 (en) Methods of and compositions for detecting ligand pair bonds using non-fluoroscent labelling
EP0850417A4 (en) EFFICIENT PROCESS FOR ENRICHMENT AND DETECTION OF DISSEMINATED TUMOR CELLS
DE69721258T2 (de) Markierung und auswahl von molekülen
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DK0877941T3 (da) Fremgangsmåde til masseforøgelse af en population eller subpopulation af celler
ATE493186T1 (de) Zelltrennungszusammensetzungen und -verfahren
Laghmouchi et al. Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells
Peters et al. A leucine-rich repeat variant with a novel repetitive protein structural motif
TW429166B (en) Method for separating plastics
ATE120796T1 (de) Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.
TW215898B (enExample)
WO1993020103A3 (en) Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification
GB9014294D0 (en) Assay for cytotoxic t cells
Nelson et al. Origin of the effects of cell cycle age on radiation sensitivity
Kloosterman This fee includes a copy of the final program, an abstracts volume; a copy of the Proceedings; part of the social events and refreshments during the breaks. Wagons-Lits Tours, Cantersteen 41, B-lOOO-Brussels has been ap-pointed the Official Travel Agent. All correspondence should be sent to
SE8603312L (sv) Sett att overvaka fermentering
JPS6426246A (en) Automatic test system for interactive text editor